Novel Tumor-Specific Antigens for Immunotherapy Identified From Multi-omics Profiling in Thymic Carcinomas

Thymic carcinoma (TC) is the most aggressive thymic epithelial neoplasm. TC patients with microsatellite instability, whole-genome doubling, or alternative tumor-specific antigens from gene fusion are most likely to benefit from immunotherapies. However, due to the rarity of this disease, how to pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Wentao, Wu, Chia-Hsin, Sun, Qiang-Ling, Gu, Zhi-Tao, Zhu, Lei, Mao, Teng, Zhang, Xue-Fei, Xu, Ning, Lu, Tzu-Pin, Tsai, Mong-Hsun, Chen, Li-Han, Lai, Liang-Chuan, Chuang, Eric Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635231/
https://www.ncbi.nlm.nih.gov/pubmed/34867976
http://dx.doi.org/10.3389/fimmu.2021.748820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635231/
https://www.ncbi.nlm.nih.gov/pubmed/34867976
http://dx.doi.org/10.3389/fimmu.2021.748820

Ejemplares similares